Skolnick, Phil http://orcid.org/0000-0002-2646-815X
Crystal, Roger http://orcid.org/0000-0002-7190-9970
Article History
Received: 29 October 2019
Accepted: 21 December 2019
First Online: 31 December 2019
Compliance with ethical standards
:
: Drs. Skolnick and Crystal are full-time employees of Opiant Pharmaceuticals. Opiant Pharmaceuticals has licensed the rights to develop drinabant for treatment of acute cannabinoid overdose.